Savant Capital LLC Cuts Stock Position in Universal Health Services, Inc. $UHS

Savant Capital LLC lessened its holdings in Universal Health Services, Inc. (NYSE:UHS) by 29.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,770 shares of the health services provider’s stock after selling 2,813 shares during the quarter. Savant Capital LLC’s holdings in Universal Health Services were worth $1,226,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Universal Health Services in the 2nd quarter worth about $87,373,000. AQR Capital Management LLC raised its position in Universal Health Services by 57.8% in the first quarter. AQR Capital Management LLC now owns 931,355 shares of the health services provider’s stock worth $173,381,000 after acquiring an additional 340,966 shares during the period. Ameriprise Financial Inc. boosted its stake in Universal Health Services by 329.4% in the first quarter. Ameriprise Financial Inc. now owns 404,806 shares of the health services provider’s stock valued at $76,081,000 after acquiring an additional 310,531 shares during the last quarter. Nuveen LLC bought a new position in shares of Universal Health Services during the 1st quarter valued at approximately $25,555,000. Finally, Assenagon Asset Management S.A. increased its stake in shares of Universal Health Services by 119.5% during the 2nd quarter. Assenagon Asset Management S.A. now owns 241,164 shares of the health services provider’s stock worth $43,687,000 after purchasing an additional 131,305 shares during the last quarter. 86.05% of the stock is currently owned by institutional investors.

Insider Activity at Universal Health Services

In related news, Director Warren J. Nimetz sold 3,817 shares of the company’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $223.30, for a total transaction of $852,336.10. Following the sale, the director owned 8,481 shares of the company’s stock, valued at approximately $1,893,807.30. This represents a 31.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Elliot J. Md Mba Sussman sold 965 shares of the stock in a transaction that occurred on Wednesday, October 29th. The stock was sold at an average price of $225.70, for a total transaction of $217,800.50. Following the completion of the sale, the director owned 6,113 shares in the company, valued at $1,379,704.10. This represents a 13.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 16.40% of the stock is currently owned by insiders.

Universal Health Services Stock Performance

NYSE:UHS opened at $228.28 on Thursday. The business’s fifty day moving average is $204.83 and its 200 day moving average is $188.04. The firm has a market cap of $14.53 billion, a price-to-earnings ratio of 10.84, a PEG ratio of 0.80 and a beta of 1.33. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.19 and a current ratio of 1.03. Universal Health Services, Inc. has a 52-week low of $152.33 and a 52-week high of $231.37.

Universal Health Services (NYSE:UHS) last issued its earnings results on Tuesday, October 28th. The health services provider reported $5.69 EPS for the quarter, topping the consensus estimate of $4.66 by $1.03. Universal Health Services had a return on equity of 19.47% and a net margin of 8.09%.The business had revenue of $4.50 billion during the quarter, compared to the consensus estimate of $4.32 billion. During the same quarter last year, the company earned $3.71 EPS. The firm’s revenue was up 13.4% compared to the same quarter last year. Research analysts predict that Universal Health Services, Inc. will post 15.92 EPS for the current year.

Wall Street Analyst Weigh In

UHS has been the topic of several research analyst reports. Guggenheim upped their price objective on Universal Health Services from $227.00 to $253.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Wall Street Zen raised Universal Health Services from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 11th. JPMorgan Chase & Co. decreased their price objective on Universal Health Services from $215.00 to $195.00 and set a “neutral” rating for the company in a report on Monday, August 4th. UBS Group set a $231.00 price objective on shares of Universal Health Services in a report on Thursday, October 30th. Finally, Bank of America lowered shares of Universal Health Services from a “neutral” rating to an “underperform” rating and cut their target price for the stock from $215.00 to $185.00 in a research report on Wednesday, July 16th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Universal Health Services currently has a consensus rating of “Hold” and a consensus target price of $233.20.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.